Stavanger HF, Stavanger universitetssykehus
- Address
- Jan Johnsensgt 5, 4011 Stavanger, Norway
Cardiovascular Diseases
At Stavanger universitetssykehus, clinical research in cardiovascular diseases focuses on atherosclerotic cardiovascular disease and the prevention of major heart and blood vessel events. The studies are designed to evaluate whether a new treatment can better reduce the risk of serious outcomes such as cardiovascular death, heart attack, and stroke in people with established vascular disease.
- Prevention of major cardiovascular events in people with established ASCVD
- Testing a new therapy aimed at lowering LDL cholesterol and improving outcomes
This work reflects a strong interest in improving treatment effectiveness for patients at high risk of recurrent cardiovascular events.
Neoplasms
The site also conducts research in neoplasms, with a focus on colon and rectal cancer in patients with stage II-III disease and specific somatic changes in the PI3K signaling pathway. The trial activity here is centered on assessing whether an additional treatment approach can help delay or prevent cancer recurrence after initial care.
- Colorectal cancer with PIK3CA, PIK3R1, or PTEN alterations
- Evaluating adjuvant treatment to improve time to recurrence
Research at Stavanger Helseforskning includes efforts to improve outcomes for patients with colorectal cancer by studying whether a widely used medicine can support longer disease control.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Karolinska Institutet1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 112 other sites in Norway
Therapeutic Area Benchmark — Norway
Select a therapeutic area to compare against other sites in Norway.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Norway
Market Share
Country: Norway
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Stavanger HF, Stavanger universitetssykehus
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Inclisiran's Efficacy in Reducing Major Adverse Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial | Novartis Pharma AG | Phase III | Not Recruiting | Nov 2021 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.